Big contract win | Renewed focus | Recovery play
Updates from AIM covered here include news of another acquisition for one of AIM’s largest and most acquisitive companies. The shares struggled in 2023 but could offer decent recovery potential in 2024. Read on here for our thoughts on this and other news from London’s junior market. (Premium)
We aren’t overly enthusiastic about so-called ‘buy and build strategies’, especially those fuelled by more costly debt, but one company covered below has executed this far better than many others we have come across. Elsewhere, if markets do pick-up, two derivates brokers covered below could also do very nicely. Intercede lands another contract and gets another upgradeIntercede (AIM:IGP), the cybersecurity software company specialising in digital identities, which announced its largest ever contract award In December, announced the award of another major licence. The latest contract award with associated support and maintenance is approximately $1.0m for a new client in the…